 | Up a level |
Brummendorf, Tim H, Cortes, Jorge E, Milojkovic, Dragana, Gambacorti-Passerini, Carlo, Clark, Richard E 
ORCID: 0000-0002-1261-3299, le Coutre, Philipp, Garcia-Gutierrez, Valentin, Chuah, Charles, Kota, Vamsi, Lipton, Jeffrey H et al (show 9 more authors)
(2022)
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial.
, England.
Cortes, Jorge E, Candoni, Anna, Clark, Richard E ORCID: 0000-0002-1261-3299, Leber, Brian, Montesinos, Pau, Vyas, Paresh, Zeidan, Amer M and Heuser, Michael
(2020)
Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review.
Leukemia and Lymphoma, 61 (14).
pp. 3287-3305.